SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis

Giuseppe Lo Sasso1, Keir Joe Menzies1, Adrienne Mottis1

  • 1Laboratory for Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Plos One
|July 30, 2014
PubMed
Abstract

Insights

SIRT2 plays a protective role in colitis by inhibiting inflammation. Sirt2 deficiency exacerbates inflammatory bowel disease by promoting NF-κB acetylation and reducing anti-inflammatory pathways.

Area of Science:

  • Biochemistry
  • Immunology
  • Genetics

Background:

  • Sirtuin 2 (SIRT2) is an NAD+-dependent deacylase involved in regulating inflammation.
  • SIRT2 deacetylates and inhibits the p65 subunit of nuclear factor-kappa B (NF-κB).

Purpose of the Study:

  • To investigate the role of SIRT2 in dextran sulfate sodium (DSS)-induced colitis.
  • To determine the effect of Sirt2 deficiency on inflammatory responses in the gut.

Main Methods:

  • Generated Sirt2 deficient (Sirt2-/-) mice using homologous recombination.
  • Induced colitis in Sirt2-/- and wild-type (Sirt2+/+) littermate mice using DSS.
  • Analyzed clinical and histological manifestations of colitis and macrophage polarization.

Main Results:

  • Sirt2-/- mice exhibited more severe colitis than wild-type littermates.
  • Sirt2 deficiency did not alter basal phenotype or intestinal morphology.
  • Sirt2 deficiency promoted a pro-inflammatory environment by affecting macrophage polarization.

Conclusions:

  • SIRT2 plays a protective role in colitis, acting as a suppressor of inflammatory processes.
  • SIRT2 deletion exacerbates colitis by increasing NF-κB acetylation and reducing M2-associated anti-inflammatory pathways.
  • SIRT2 activation may represent a therapeutic strategy for inflammatory bowel disease.